Tools for assessing for equity
|
|
6
|
3871
|
September 20, 2021
|
Pre-testing two competing surveys with overlapping items
|
|
0
|
1655
|
September 3, 2021
|
How to update a prognostic model of COVID-19 for the effect of vaccination
|
|
3
|
2476
|
August 7, 2021
|
Prediction model with one very strong predictor and other predictors?
|
|
3
|
2589
|
August 5, 2021
|
Survey Non-Response Weighting Stata
|
|
11
|
9973
|
June 13, 2021
|
Default Using R package to implement Bayesian phase I/II dose-finding design for three outcomes
|
|
10
|
3470
|
June 10, 2021
|
Bootstrap and prior distribution method for self-controlled case series design
|
|
0
|
2126
|
June 9, 2021
|
Statistical conundrum: multiple noisy measurements vs an oracle
|
|
7
|
21959
|
May 24, 2021
|
Association of continuous outcomes with binary endpoints; and "optimal" cut-off points
|
|
3
|
2386
|
May 3, 2021
|
Provisions for outilers and strategies
|
|
2
|
3273
|
March 15, 2021
|
Advice on study design
|
|
6
|
3977
|
March 3, 2021
|
Early use of tocilizumab and steroids does not impact expansion or persistence of CAR T cells in B-ALL?
|
|
2
|
3250
|
February 17, 2021
|
Does removing other events from training data amount to data snooping?
|
|
4
|
2763
|
February 10, 2021
|
RCT trials for COVID study vaccines
|
|
0
|
3084
|
October 24, 2020
|
CAR T Cells - Major Challenges (Research Methods/Design, Treatment Comparison/Design)
|
|
0
|
2081
|
October 22, 2020
|
Bayesian solution for study designs
|
|
0
|
3084
|
September 24, 2020
|
Bayesian Solutions for Challenges to Frequentist Statistics
|
|
0
|
5272
|
September 22, 2020
|
Vaccine RCTs - should number of COVID events trigger unblinding?
|
|
2
|
3057
|
September 21, 2020
|
Analysing proportions from replicated experiments
|
|
0
|
1840
|
September 2, 2020
|
De-dichotimization of diagnostic testing for increased confidence
|
|
9
|
5211
|
April 30, 2020
|
Questions on modelling strategies in binary logistic regression from two papers
|
|
4
|
2997
|
April 11, 2020
|
French target trial using obs data of HCQ vs not in SARS-CoV-2 infection
|
|
0
|
2892
|
April 15, 2020
|
Type I error in a specific design of 2-parallel group study
|
|
3
|
3580
|
March 11, 2020
|
Validation of population-based registries
|
|
3
|
3995
|
February 24, 2020
|
Time-to-event analysis in nested case-control designs
|
|
0
|
2809
|
February 16, 2020
|
Are synthetic controls tantamount to clinical prediction models?
|
|
1
|
3198
|
February 15, 2020
|
When to use absolute vs relative effect measures
|
|
13
|
20495
|
February 8, 2020
|
Identifying patients through phenotype definition
|
|
7
|
4600
|
January 5, 2020
|
Why significant variable doesn't improve model performance?
|
|
1
|
3112
|
January 2, 2020
|
Conditional Independence Assumption
|
|
2
|
4089
|
September 30, 2019
|